167 related articles for article (PubMed ID: 15006283)
1. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).
Mason PJ; Manson JE; Sesso HD; Albert CM; Chown MJ; Cook NR; Greenland P; Ridker PM; Glynn RJ
Circulation; 2004 Apr; 109(13):1623-9. PubMed ID: 15023883
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
Lonn EM; Yusuf S
Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
[TBL] [Abstract][Full Text] [Related]
4. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
5. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial.
Zhang SM; Cook NR; Albert CM; Gaziano JM; Buring JE; Manson JE
JAMA; 2008 Nov; 300(17):2012-21. PubMed ID: 18984888
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
de Bree A; Mennen LI; Hercberg S; Galan P
Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
[TBL] [Abstract][Full Text] [Related]
8. Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
Wenger NK
Cardiol Rev; 2007; 15(6):288-90. PubMed ID: 18090063
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
10. Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women.
Christen WG; Glynn RJ; Chew EY; Albert CM; Manson JE
Ophthalmic Epidemiol; 2016; 23(1):32-9. PubMed ID: 26786311
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
[TBL] [Abstract][Full Text] [Related]
12. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group.
Manson JE; Gaziano JM; Spelsberg A; Ridker PM; Cook NR; Buring JE; Willett WC; Hennekens CH
Ann Epidemiol; 1995 Jul; 5(4):261-9. PubMed ID: 8520707
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Bostom AG; Carpenter MA; Kusek JW; Hunsicker LG; Pfeffer MA; Levey AS; Jacques PF; McKenney J;
Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
[TBL] [Abstract][Full Text] [Related]
14. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of participants in the Women's Health Study.
Rexrode KM; Lee IM; Cook NR; Hennekens CH; Buring JE
J Womens Health Gend Based Med; 2000; 9(1):19-27. PubMed ID: 10718501
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E and cardiovascular disease: observational studies.
Gaziano JM
Ann N Y Acad Sci; 2004 Dec; 1031():280-91. PubMed ID: 15753154
[TBL] [Abstract][Full Text] [Related]
17. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
Manson JE; Buring JE; Satterfield S; Hennekens CH
Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
[TBL] [Abstract][Full Text] [Related]
18. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.
Kang JH; Cook N; Manson J; Buring JE; Albert CM; Grodstein F
Am J Clin Nutr; 2008 Dec; 88(6):1602-10. PubMed ID: 19064521
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in women with and without rheumatoid arthritis.
Solomon DH; Curhan GC; Rimm EB; Cannuscio CC; Karlson EW
Arthritis Rheum; 2004 Nov; 50(11):3444-9. PubMed ID: 15529391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
